Roche’s Genentech more than doubles investment in North Carolina facility to about $2 billion
Jan 20 (Reuters) – Roche’s Genentech said on Tuesday it will more than double its initial investment in a biomanufacturing facility in North Carolina to about $2 billion, as the companies look to further boost their $50 billion investment in the U.S. The facility, based in Holly Springs, North Carolina is set to be operational … Read more